Saturday, August 29, 2020

// // Leave a Comment

Wistar Institute COVID-19 vaccine phase 1 trial elicits immune response in all participants

Four months after the Wistar Institute and Penn Medicine began testing its COVID-19 vaccine, all trial participants have demonstrated an overall immune response and experienced little to no side effects. Phases two and three of the study are expected to ...

from Google Alert - health https://ift.tt/3hJN91u
via IFTTT

0 comments:

Post a Comment